Skip to main content

Table 2 Results of the quantitative 1H NMR determination of total statins in red yeast rice products

From: NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements

Sample

Sample Labelling

Product origin

Total statins (NMR)

Labelling of monacolin K

(mg/capsule)

(mg/capsule) a

(mg/daily dose) b

S1

Red rice, food supplement, 330 mg capsules (in German)

Austria

1.5 ± 0.1

1.5 - 4.5

1.33

S2

Red yeast rice, food supplement, 600 mg capsules (in English)

USA with UK labelling

3.3 ± 0.4

6.6

no labelling

S3

Red yeast rice, herbal supplement, 330 mg capsules (in English)

UK

5.3 ± 0.6

10.6

no labelling

S4

Red yeast rice, dietary supplement, 600 mg capsules (in English)

USA

6.3 ± 0.2

12.6 - 25.2

no labelling

S5

Red yeast rice, food supplement, 600 mg capsules (in French)

France

8.0 ± 0.6

16.0 - 24.0

9.6

  1. a Means ± standard deviations (SD) based on 5 replicated measurements (including sample preparation)
  2. b The daily doses were calculated according to our analytical result and the intake recommendation of the products (a range is given when the manufacturer recommended a range for daily dose)